Shares of Allurion (NYSE:ALUR) soared 70% in post-market trading Thursday after ending the regular session 21% higher on news the company plans to conduct a clinical study of its gastric balloon ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback